摘要
前列腺癌（PC）是泌尿系常见的恶性肿瘤,也是当前威胁全世界老年男性健康的主要恶性肿瘤。不但是欧美发达国家最常见恶性肿瘤之一,而且在我国的发病率也呈明显上升趋势。关于前列腺癌的诊断,尤其是早期诊断,日益受到人们的重视。在众多的检测方法中。
出处
《实用中西医结合临床》
2013年第4期92-94,共3页
Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
参考文献26
-
1Thompson IM, Pauler DK, Goodman P J, et al. Prevalence of prostate cancer among men with a prostate specific antigen level or 4.0 ng per milliliter[J]. N Engl J Med,2004,351(14):1470.
-
2Mistry K, Cable G. Meta-analysis of prostate specific antigen and digital rectal examination as screening tests for prostate carcinoma [J].J Am Board Faro Pract,2003,16:95-101.
-
3Jonathan L, Paul H. Newer potential biomarkers in prostate cancer [J]. Reviews In Urology, 2007,9(4):207-213.
-
4Dipen J, Parekh, Ankerst DP ,et al. Thompson: Biomarkers for prostate cancer detection [J]. The Journal of Urology,2007,178: 2 252-2 259.
-
5Mikolajczyk SD, Rittenhouse HG. Pro- PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer[J]. Keio J Med,2003,52(2):86-91.
-
6Ghosh A,Wang X,Klein E, et al.Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness [J]. Cancer Res,2005,65(3) : 727 -731.
-
7Rajasekaran AK,Anilkumar G, Christiansen JJ, et alJs prostate-specific membrane antigen a multifunctional protein [J]. Am J Physiol Cell Physiol,2005,288 (5) :C975 -C981.
-
8Ra.jasekaran SA, Christiansen ]],Schmid I,et al.Prostate-specific membrane antigen associates with anaphase -promoting complex and induces chromosomal instability [J].Moi Cancer Ther, 2008,7 (7):2 142-2 151.
-
9Colombatti M,Grasso S, Porzia A,et al.The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating,the MAPK pathways[J].Plos One, 2009,4(2) :e4 608.
-
10Anilkumar G, Rajasekaran SA,Wang S,et al.Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity [J], Cancer Res,2003,63 (10) : 2 645 -2 648.
同被引文献28
-
1ItoK,MiyakuboM,SekinY,etal.Diagnosticsignificanceofpro-PSA andprostatedimension-adjustedPSA-relatedindicesinmenwithtotalPSAinthe2.0-10.0ng/mLrange[J].WorldJUrol,2013,31(2):305-311.
-
2CrawfordED,VentiiK,ShoreND.Newbiomarkersinpros-tatecancer[J].Oncology(WillistonPark),2014,28(2):135-142.
-
3DarianeC,LeCossecC,DrouinSJ,etal.Comparisonofoncologicoutcomesafterradicalprostatectomyinmendia-gnosedwithprostatecancerwithPSA levelsbelowandabove4ng/mL[J].WorldJUrol,2014,32(2):481-487.
-
4KitagawaY,UenoS,IzumiK,etal.Cumulativeprobabilityofprostatecancerdetectioninbiopsyaccordingtofree/to-talPSAratioinmenwithtotalPSAlevelsof2.1-10.0ng/mlatpopulationscreening[J].JCancerResClinOncol,2014,140(1):53-59.
-
5CaryKC,CooperbergMR.Biomarkersinprostatecancersurveillanceandscreening:past,present,andfuture[J].TherAdvUrol,2013,5(6):318-329.
-
6JiangN,ZhuS,ChenJ,etal.A-methylacyl-CoAracemase(AMACR)andprostate-cancerrisk:ameta-analysisof4,385participants[J].PLoSOne,2013,8(10):e74386.
-
7ChoiSY,ChangIH,KimYS,etal.Prostatespecificanti-genvelocityperprostatevolume:anoveltoolforprostatebiopsyprediction[J].Urology,2011,78(4):874-879.
-
8JananeA,HajjiF,IsmailT,etal.Usefulnessandpredic-tivevalueofPSAdensity,adjustedbytransitionzonevolu-me,inmenwithPSAlevelsbetween2and4ng/ml[J].ActasUrolEsp,2012,36(2):93-98.
-
9ChenZ,SunJ,Kim ST,etal.Genome-wideassociationstudyidentifiesgeneticdeterminantsofurinePCA3levelsinmen[J].Neoplasia,2013,15(4):448-453.
-
10SalagierskiM,SosnowskiM,SchalkenJA.Howaccurateisourpredictionofbiopsyoutcome- PCA3-basednomo-gramsinpersonalizeddiagnosisofprostatecancer[J].CentEuropeanJUrol,2012,65(3):110-112.
二级引证文献3
-
1王月强.血清FSTL1在老年前列腺癌患者中的应用价值探讨[J].国际医药卫生导报,2015,21(23):3435-3436.
-
2陈亮,吴波.前列腺癌实验室早期诊断研究进展[J].深圳中西医结合杂志,2016,26(11):181-183.
-
3张立华,张铁征,王晓,张明.早期前列腺癌抗原-2和人类腺体激肽释放酶2在前列腺癌诊断中的临床意义[J].河北医药,2017,39(5):686-690. 被引量：7
-
1毛建英,冯建中,盛陈卓娅,潘建强,平金良,马志红.上皮细胞黏附分子在非小细胞肺癌组织中表达及其临床意义[J].中华实验外科杂志,2016,33(11):2576-2579. 被引量：4
-
2时昊,张志瑢,肖爱琴,朱锋,张日.c-kit受体与其他髓系膜抗原标志物对急性非淋巴细胞白血病诊断价值的比较[J].中华内科杂志,2005,44(5):384-385. 被引量：12
-
3杜林栋,王文营,李炫昊.前列腺癌诊断标志物研究现状[J].临床泌尿外科杂志,2009,24(8):565-567. 被引量：2
-
4卢志明,陈国健.胰腺癌肿瘤标志物[J].山东医药,2006,46(11):69-69. 被引量：1
-
5何竞(综述),马贤凯(审校).EPCA：早期前列腺癌检测的新指标[J].国际泌尿系统杂志,2008,28(3):309-311.
-
6窦建国,王德林.前列腺癌诊断的潜在新标志物[J].实用医院临床杂志,2010,7(2):133-135. 被引量：1
-
7刘建国,韩秋菊,尉继伟.外照射与局部热疗对荷VX_2瘤兔细胞因子的影响[J].肿瘤研究与临床,2006,18(11):728-730. 被引量：8
-
8胡利平,刘振湘.EPCA对早期前列腺癌的诊断作用[J].海南医学,2009,20(9):137-140. 被引量：2
-
9沈立,沈红,杜兴冉,杜强,朱成华.晚期非小细胞肺癌外周血EGFR基因检测与肿瘤抗原标志物的临床意义[J].临床肺科杂志,2017,22(4):614-617. 被引量：1
-
10杨家佳,张琳,郑茂金,柳红.肿瘤干细胞标记物CD44和EpCAM在胃癌中的表达及意义[J].徐州医学院学报,2014,34(10):661-664. 被引量：3
